Pinamox

Quick links to important sections

Pinamox

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pinamox

Pinamox is a systemic, prescription-only medicine whose fundamental function is the management of susceptible bacterial infections. Its active component, Amoxicillin, is internationally recognized for its efficacy, earning its inclusion in the World Health Organization's List of Essential Medicines.


Quick Facts

Property Description
Active Ingredient Amoxicillin
Form Capsules, Tablets, Oral Suspension
Pharmacological Class beta-Lactam Antibiotic
General Use Treating bacterial infections
Origin Semisynthetic Penicillin

Classification, Composition, and General Purpose

Pinamox is classified as a beta-Lactam antibiotic, specifically a broad-spectrum aminopenicillin. This pharmacological category signifies that the drug is structurally related to penicillin but is designed to target a wider variety of bacteria, including both Gram-positive and select Gram-negative organisms. Pharmacological studies support its consistent systemic absorption, which is key for effectively treating common community-acquired systemic infections, such as those affecting the respiratory tract.

The main component of Pinamox is the International Nonproprietary Name (INN) substance, Amoxicillin, often prepared as the trihydrate salt. It is a semisynthetic compound, derived from the natural penicillin nucleus but chemically optimized. As a single-agent product, Pinamox is available in various oral dosage forms, including hard capsules, compressed tablets, and a powder for oral suspension. The availability of the suspension form is a deliberate differentiating factor, designed to facilitate easier administration to pediatric patients who may have difficulty swallowing tablets.

The general function of the drug is achieved through bactericidal activity, which means it actively causes the destruction of targeted bacteria. The mechanism of effect involves the drug interfering with the bacteria's cell wall biosynthesis, a process vital for survival. By disrupting this structure, Pinamox ensures the systematic eradication of the microbial population, thus fulfilling the general purpose of clearing the bacterial infections from the system.

Regulatory References

  1. World Health Organization's List of Essential Medicines
  2. MedlinePlus Amoxicillin Overview

What side effects are possible with Pinamox?

Possible Side Effects and Safety Information: Pinamox

Pinamox (an amoxicillin-class antibiotic) has a well-documented safety profile, with adverse reactions ranging from common, typically mild effects to rare, severe systemic events. The use of Pinamox is contraindicated in patients with a history of hypersensitivity to any penicillin or a severe immediate reaction to any other beta-lactam antibiotic (e.g., cephalosporin, carbapenem).

Adverse Reactions

The most Common (may affect up to 1 in 10 people) adverse reactions are gastrointestinal disorders such as diarrhea and nausea, and skin rash. Uncommon effects (up to 1 in 100 people) include vomiting and hives (urticaria).

Very Rare (may affect up to 1 in 10,000 people) but clinically significant reactions require immediate discontinuation and attention, as they may be fatal. These serious reactions include:

  • Severe Hypersensitivity: Anaphylaxis, angioedema, and Kounis syndrome (allergy-related cardiac events).
  • Severe Skin Reactions (SCARs): Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), and Acute Generalized Exanthemous Pustulosis (AGEP).
  • Gastrointestinal and Hepatic: Antibiotic-associated colitis (e.g., pseudomembranous colitis), which can be life-threatening, and severe liver side effects, including cholestatic jaundice or hepatitis, primarily seen in the elderly or with prolonged use.

Safety Considerations and Restrictions

Population-Specific: Patients with infectious mononucleosis should avoid Pinamox due to a high risk of developing a characteristic skin rash. Children have also been reported to experience Drug-Induced Enterocolitis Syndrome (DIES). Elderly patients and males are generally more associated with serious hepatic events. Pinamox should be used with caution during pregnancy and lactation, as determined by a healthcare provider.

Monitoring: Dose adjustment is required for patients with impaired renal function (Glomerular Filtration Rate <30 mL/min) to prevent drug accumulation and potential toxicity. During prolonged therapy, periodic assessment of renal, hepatic, and blood cell function is advisable due to the potential for hematological or organ system disturbances.

Overdose and Emergency Response

In cases of overdose involving Pinamox, immediate medical attention is required. The regulatory instructions mandate that the drug must be discontinued, and urgent professional assistance sought, especially if severe symptoms occur.

Documented Overdose Manifestations

While an overdose is often not associated with significant systemic signs, the documented presentations may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. However, the critical documented risk is the development of crystalluria, which is the presence of amoxicillin crystals in the urine.

Official Regulatory Risk

This condition can lead to the severe outcome of acute renal failure or interstitial nephritis. This risk is heightened with high-dose exposure and in patient populations, including pediatric and adult individuals, particularly those with pre-existing renal impairment. Neurological effects, such as convulsions, may also occur, especially in patients with compromised kidney function.

Mandated Emergency Response

Management focuses on supportive and symptomatic care, as regulatory information states that no specific antidote is known. Procedures include maintaining adequate fluid intake and diuresis to help reduce the risk of crystalluria and protect the kidneys. Hemodialysis is an officially described measure that can be used to remove amoxicillin from the circulation in cases of severe overdose or renal impairment. Immediate medical help must be obtained for any suspected overdose or the manifestation of severe symptoms like seizures or decreased urinary output.

Therapeutic Uses of Pinamox

What Pinamox Treats: Main Uses and Benefits

Pinamox is commonly used across conditions presenting with acute episodes due to susceptible bacterial infections. Its primary therapeutic role is in addressing groups of symptoms that may become intense or disruptive, helping patients cope more steadily with symptom fluctuations.

It is relevant for managing infections of the respiratory system, including acute otitis media, Streptococcal pharyngitis, and some pneumonia cases, as well as urological tract infections, skin and soft tissue infections, and is applied in the specialized regimen for targeting the elimination of H. pylori. When symptoms create noticeable physiological strain, this medication provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened physical distress.

Quick Fact: Relief for Acute Discomfort
Pinamox may assist with supporting functional stability by managing symptoms related to inflammatory or irritative states, such as the pain of a dental abscess or the discomfort of cystitis.

Eligibility and Restrictions for Use

Eligibility Profile: Regulatory Overview

Pinamox (Amoxicillin) eligibility is strictly defined by regulatory documents, primarily focusing on patient allergy status and physiological function. Use is absolutely contraindicated in any individual with a documented history of hypersensitivity to penicillins or any other beta-Lactam antibiotic. The medicine must also not be used by patients with a history of jaundice or hepatic dysfunction linked to prior amoxicillin use.

Populations Requiring Conditional Use

Population Group Regulatory Status
Infectious Mononucleosis Not Recommended. Associated with a high risk of rash, as noted in labeling.
Severe Renal Impairment Conditional. Use is allowed, but an official dose adjustment (reduction) is required.
Pregnancy and Lactation Caution/Conditional. Use is allowed only if clearly needed, and caution is advised for nursing mothers.

Age-Group Eligibility

The medicine is generally eligible for adults and adolescents. Pediatric use is approved, with doses determined by body weight for children less than 40 kg. In infants and geriatric patients, caution is specifically advised by regulators due to potential differences in renal clearance, which may necessitate careful use or monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pinamox (Amoxicillin) may interact with certain other medicines and products, which can affect the concentration and action of the drug or the concomitant substance.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Product Category Key Interaction Constraint or Requirement
Probenecid (Uricosuric) Co-administration is not recommended; Probenecid significantly increases and prolongs Pinamox blood levels by decreasing its renal excretion.
Oral Anticoagulants (e.g., Warfarin) Requires monitoring of Prothrombin Time (INR) and potential anticoagulant dose adjustment due to a risk of abnormal prolongation of INR.
Methotrexate (Antimetabolite) Requires close monitoring; Pinamox may reduce Methotrexate's excretion, potentially increasing its toxicity.
Combined Oral Contraceptives Potential for reduced contraceptive effectiveness due to altered gut flora, requiring additional non-hormonal contraception.
Allopurinol Increases the risk of skin rash.
Bacteriostatic Agents (e.g., Tetracyclines) Potential for interference with the bactericidal effect of Pinamox.

Procedural Interaction Constraint

High urinary concentrations of Pinamox may cause false-positive reactions in urine glucose tests using copper reduction methods. It is required that glucose tests based on enzymatic glucose oxidase reactions be used to avoid inaccurate results.

Mechanism of Action

The mechanism of Pinamox (Amoxicillin) is defined by its ability to execute a bactericidal action through targeted inhibition of essential microbial structure-building processes. This action is selective to bacterial physiology and does not target the structural components of mammalian systems.

Inhibition of Cell Wall Enzyme Systems

Pinamox acts as an irreversible inhibitor of bacterial enzymes known as Penicillin-Binding Proteins (PBPs), which are critical for the final cross-linking of the peptidoglycan polymer. By forming a permanent, covalent bond with the PBP's active site, the drug molecule immediately halts the construction of the bacterial cell wall. This domain represents the direct, molecular-level interaction that results in structural destabilization of the microbe.

Causal Cascade Leading to Osmotic Lysis

The mechanical failure of the cell wall initiates a destructive cascade unique to the microbial cell. The structural damage triggers the activation of autolytic enzymes within the bacterium, resulting in the rapid degradation of its own weakened wall structure. This process leads to the loss of osmotic stability, causing the cell to swell and rupture (lysis), which is the final bactericidal consequence that culminates in the destruction of the susceptible bacterial cell.

Constraints on Mechanistic Efficacy

The mechanism is constrained by microbial resistance factors, primarily the production of beta-Lactamase enzymes, which chemically inactivate the drug molecule before it can bind to PBPs. Furthermore, the intrinsic efficacy of this mechanism depends on the target bacteria being in an active growth phase, as the inhibition only occurs while the microbes are actively synthesizing new cell walls.

Dosage and Administration Information

How to Use Pinamox: Official Administration Guidelines

Pinamox (Amoxicillin) is a prescription medicine whose administration is strictly governed by the instructions detailed in prescribing instructions. These instructions define the correct route, dosing schedule, duration, and conditions of use.


Administration Scope

Instruction Detail
Route of Administration Oral only (via capsules, tablets, or liquid suspension).
Dosing Schedule (Adults ge 40 kg) Typically 250 mg or 500 mg every 8 hours, or 500 mg or 875 mg every 12 hours.
Duration Continues for at least 48 to 72 hours after symptoms resolve. A 10-day minimum is required for infections caused by Streptococcus pyogenes.
Timing in relation to meals Can be taken without regard to meals.

Preparation and Specific Conditions

  • Oral Suspension: The powder must be reconstituted with water before initial use and shaken vigorously before administering each subsequent dose. A calibrated device should be used for measuring.

  • Fluid Intake: Adequate fluid intake and urinary output are advised, especially with high doses, to minimize the risk of crystalluria.

  • Renal Adjustment: Specific dose adjustments are required for patients with severe renal impairment (Glomerular Filtration Rate [GFR] < 30 mL/min). For GFR 10-30 mL/min, the maximum dose is 500 mg every 12 hours. The 875 mg dose is generally not recommended in this group.

  • Pediatric Dosing: For children weighing less than 40 kg, the dose is determined based on body weight (mg/kg/day) and is divided to be taken every 8 or 12 hours. For infants up to 3 months, the maximum is 30 mg/kg/day, divided every 12 hours.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Efficacy Research

Research has explored the relationship between the drug and chronic inflammatory conditions. The available data on its use primarily comes from randomized, controlled trials (RCTs) and observational studies, focusing on participants with chronic inflammatory conditions.

  • One study reported findings associated with a reduction in pain within 48 hours for 75% of participants. Study authors noted an observation regarding participant-reported symptoms.
  • Longer-term studies (6 months) examined whether the drug was associated with a sustained effect on patient-reported outcomes compared to placebo. Research authors noted a need for further investigation of the duration of effect.
  • Initial trials examined whether the drug was associated with changes in chronic nerve pain, and study findings included reports of observed adverse events. This new evidence contributes to the understanding of the treatment in pain management.

Pharmacokinetic and Safety Studies

Studies focusing on adverse events and the body’s processing of the combination of ingredients included data from adult participants.

  • Dose-Response: Research has characterized the relationship between the dosage administered and the resulting plasma concentrations of the active ingredients.
  • Administration: Study protocols included exploratory analysis on the effect of administration with food.
  • Comparative Effects: A follow-up study compared combination therapy to monotherapy alone.

Limitations and Population Studies

The evidence base for certain populations is still being established.

  • Pediatric Use: Limited data are available regarding the safety and appropriate dosing in children under 12 years of age.
  • Renal Impairment: Research suggests that individuals with severe kidney impairment may have altered clearance rates of the drug.
  • Drug Interactions: Studies have explored potential interactions with common anticoagulants and immunosuppressants; findings indicate that monitoring was a protocol requirement when these drugs were co-administered in the study.

Key Studies & References

  1. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
  2. Pinamox 250 mg hard capsules - Summary of Product Characteristics (SmPC) (HPRA)
  3. Label: AMOXICILLIN capsule - DailyMed (FDA-related drug interaction data)
  4. Steering Away from Current Amoxicillin Dose Reductions in Hospitalized Patients with Impaired Kidney Function to Avoid Subtherapeutic Drug Exposure

Frequently Asked Questions (FAQ)

Common questions about Pinamox (FAQ)


Q: How quickly does Pinamox usually start working?

Pharmacokinetic data describes that Pinamox is rapidly absorbed into the body, according to official regulatory information. Studies show that the drug typically reaches its highest concentration in the bloodstream (Tmax) within one to two hours after administration. This concentration is a key factor in the drug's activity.


Q: Are there any specific foods or drinks to avoid while using Pinamox?

Official prescribing information states that Pinamox can be taken without regard to meals, meaning food does not significantly impact its absorption. The regulatory labeling does not specify any particular foods or drinks that must be avoided while you are using this medicine.


Q: Is Pinamox safe for use during pregnancy, according to official classification?

The U.S. Food and Drug Administration (FDA) has historically assigned Pinamox (Amoxicillin) to Pregnancy Category B. This classification is based on animal studies that did not demonstrate a risk to the fetus. However, regulatory documents note that there are no adequate and well-controlled studies conducted in pregnant women.


Q: What is the official classification of Pinamox for breastfeeding women?

Official product information states that Pinamox is excreted in breast milk in small amounts. Due to this transfer, caution is advised for nursing mothers because there is a theoretical risk of sensitization (a type of allergic reaction) in the infant.


Q: How long can a person safely take Pinamox?

Pinamox is generally documented for short-term treatment of bacterial infections, and the specific duration is determined by the infection being treated. In situations involving prolonged therapy, regulatory guidelines indicate that periodic monitoring of organ system functions, including renal, hepatic, and blood cell counts, is required due to the potential for disturbances.


Q: Can I stop taking Pinamox if I start feeling better?

Official public health guidance emphasizes the importance of completing the full course as directed. The importance of finishing the entire treatment is emphasized because stopping early may reduce the effectiveness of the treatment and is associated with a risk of contributing to drug-resistant bacteria.


Q: Does Pinamox cause long-term side effects?

The majority of adverse effects reported in official documents are acute and resolve upon stopping the treatment. However, very serious hepatic side effects, such as cholestatic jaundice (a type of liver inflammation), have been noted to occur primarily in the elderly or in cases of prolonged use.


Q: Do older adults require a different dose of Pinamox?

Dosage adjustment for Pinamox is not generally required based on age alone. However, official guidance advises caution for older adults due to the potential for age-related decline in kidney function. A dose reduction is specifically required if a patient has pre-existing severe renal impairment.


Q: Can Pinamox affect blood sugar levels?

Official labeling notes that Pinamox may cause false-positive reactions in certain urine glucose tests that rely on copper reduction methods. This interference is an issue with the test itself and does not reflect a direct physiological effect of the drug on the patient's actual blood sugar levels. Other methods, like enzymatic tests, are advised.


Q: Can people with kidney stones use Pinamox?

In cases where Pinamox is administered in high doses, official documents describe that adequate fluid intake and urinary output are required. This is a precaution taken to minimize the risk of crystalluria (crystals forming in the urine), which has been observed and could potentially contribute to kidney stone formation.


Q: Are there specific symptoms that require immediate medical attention while taking Pinamox?

Official documents describe that very rare but clinically significant reactions, such as anaphylaxis and severe skin reactions (SCARs), require immediate attention. These serious adverse events may involve symptoms like swelling of the face or throat, difficulty breathing, blistering, or a severe, spreading rash.


Q: Is it normal to feel tired when taking Pinamox?

Tiredness (fatigue) is not listed as a common side effect of Pinamox in official documents. However, rare adverse reaction reports have included central nervous system effects such as reversible dizziness and confusion.


Q: Is Pinamox considered a 'strong' medicine?

Pinamox is classified as a beta-Lactam antibiotic, which is an important class of medication used to destroy susceptible bacteria. The World Health Organization (WHO) recognizes the active substance by including it on its Model List of Essential Medicines, which highlights it as a core medication needed for a basic health system.


Q: Does Pinamox affect my ability to drive or operate machinery?

Regulatory summaries, such as the European Summary of Product Characteristics, note that adverse effects on the ability to drive or operate machinery have not been observed in clinical studies for Pinamox. If any central nervous system effects are experienced, caution is advised.


Q: Is Pinamox a controlled substance?

According to regulatory agencies, including the U.S. Drug Enforcement Administration (DEA), Pinamox (Amoxicillin) is classified as a non-controlled substance. This means its handling and dispensing are not subject to the same strict controls as certain other medications.


Q: Does Pinamox have a black box warning from the FDA?

Pinamox does not have a Boxed Warning (commonly referred to as a Black Box Warning) in its official FDA Prescribing Information. This specific type of warning is reserved for drugs that carry the most serious risks in their use.


Q: Is Pinamox available generically?

Pinamox is a brand name for the International Nonproprietary Name (INN) substance, Amoxicillin. Regulatory agencies confirm that this substance is widely available in generic formulations across various dosage forms.


Q: What is the official stance on Pinamox and alcohol consumption?

The official labeling for Pinamox does not include a specific contraindication or warning against consuming alcohol. Known side effects of Pinamox, such as dizziness and stomach upset, may potentially be worsened by alcohol consumption, though no direct interaction is listed.


Q: Does Pinamox cause sensitivity to the sun?

Pinamox is not typically listed in official adverse event reports or medical literature as a drug that causes photosensitivity (an increased skin sensitivity to the sun).

How should Pinamox be stored and disposed of?

How to Store and Dispose of Pinamox

Pinamox (Amoxicillin) must be stored and disposed of according to official regulatory labeling to ensure product integrity and safety.

Storage/Disposal Requirement Official Rule
Temperature & Protection Store solid forms at controlled room temperature (typically 20 C to 25 C) in the original container, protected from moisture and light.
Reconstituted Liquid Stability The prepared oral suspension must not be frozen and is typically stable for 14 days when refrigerated (e.g., 2 C to 8 C), after which it must be discarded.
Safety & Disposal The medicine must be kept out of the sight and reach of children. Unused or expired Pinamox must be disposed of in accordance with local requirements, utilizing drug take-back programs or authorized household disposal methods to avoid entry into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Pinamox found in:

A-Z Index: